OPKO HEALTH, INC. - 29 Jul 2024 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role
10%+ Owner
Signature
Steven D. Rubin, Exec. VP - Administration
Issuer symbol
WGS
Transactions as of
29 Jul 2024
Net transactions value
-$1,692,890
Form type
4
Filing time
31 Jul 2024, 17:03:04 UTC
Previous filing
26 Jul 2024
Next filing
02 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WGS Class A Common Stock Sale $1,692,890 -50,000 -1.6% $33.86 3,073,403 29 Jul 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from 33.56 to $34.16, inclusive. The reporting person undertakes to provide to GeneDx Holding Corp. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.